- Trials with a EudraCT protocol (60)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
60 result(s) found for: Free Energy.
Displaying page 1 of 3.
EudraCT Number: 2014-002720-27 | Sponsor Protocol Number: 2014-002720-27 | Start Date*: 2014-12-04 |
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | ||
Full Title: Simplification from Tenofovir plus Lamivudine or Emtricitabine plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir plus Lamivudine in Virologically-Suppressed-HIV-Infected Adu... | ||
Medical condition: Chronic HIV infection. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000238-23 | Sponsor Protocol Number: ExeBAT01 | Start Date*: 2016-08-09 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: The effect of Exenatide on brown adipose tissue activity and energy expenditure in healthy young men | ||
Medical condition: Healthy volunteers, intended indications: obesity and dyslipidemia | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-001594-40 | Sponsor Protocol Number: UNOLE0526 | Start Date*: 2016-05-10 | |||||||||||
Sponsor Name:University of Leicester | |||||||||||||
Full Title: SGLT-2 Inhibitor Empagliflozin Effects on Appetite and Weight Regulation: A randomised double-blind placebo-controlled trial (SEESAW) | |||||||||||||
Medical condition: Type 2 diabetes mellitus | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004059-34 | Sponsor Protocol Number: C7Q040 | Start Date*: 2021-02-25 | |||||||||||
Sponsor Name:Leiden University Medical Center | |||||||||||||
Full Title: Stimulation of the beta-2 adrenergic receptor for activating human brown adipose tissue | |||||||||||||
Medical condition: Obesity, overweight, lipid- and glucose metabolism | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000322-19 | Sponsor Protocol Number: UX007-CL202 | Start Date*: 2016-06-06 |
Sponsor Name:Ultragenyx Pharmaceutial Inc. | ||
Full Title: An Open-label Long-Term Safety and Efficacy Extension Study in Subjects with Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) Previously Enrolled in UX007 or Triheptanoin Studies | ||
Medical condition: Long-Chain Fatty Acid Oxidation Disorders (LC-FAOD) | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2019-000730-19 | Sponsor Protocol Number: DC2019ROCKIES1 | Start Date*: 2020-03-05 |
Sponsor Name:Amsterdam Univeristy Medical Center - Vu Univeristy Medical Center | ||
Full Title: A phase 4, monocenter, prospective, randomized, placebo-controlled, double-blind, cross-over mechanistic intervention trial to assess effect of 4-week Ertugliflozin (SGLT-2 inhibitor) therapy on re... | ||
Medical condition: Type 2 Diabetes Mellitus | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-002909-10 | Sponsor Protocol Number: P137 | Start Date*: 2022-10-24 |
Sponsor Name:Maastricht University | ||
Full Title: THE IMPACT OF PSILOCYBIN ON PAIN IN FIBROMYALGIA PATIENTS AND HEALTHY VOLUNTEERS: A MULTICENTER TRIAL | ||
Medical condition: Fibromyalgia | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002539-32 | Sponsor Protocol Number: The_WE_Study | Start Date*: 2015-03-23 | |||||||||||
Sponsor Name:St. Olavs University Hospital | |||||||||||||
Full Title: The WE Study - Walking Easier with cerebral palsy | |||||||||||||
Medical condition: cerebral palsy | |||||||||||||
|
|||||||||||||
Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NO (Completed) FR (Ongoing) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001063-36 | Sponsor Protocol Number: eNERGY | Start Date*: 2016-06-16 | |||||||||||
Sponsor Name:CHU Rennes | |||||||||||||
Full Title: Randomised phase III study testing nivolumab versus chemotherapy in first line treatment of PS 2 or elderly (more than 70 years old) patients with advanced non-small cell lung cancer | |||||||||||||
Medical condition: Advanced non small cell lung cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004122-18 | Sponsor Protocol Number: 2012GR12 | Start Date*: 2014-12-12 | |||||||||||
Sponsor Name:University of Dundee, Tayside Clinical Trials Unit | |||||||||||||
Full Title: A Prospective Study to Evaluate the Effect of Allopurinol on Muscle Energetics in Older People with Impaired Physical Function. | |||||||||||||
Medical condition: FUNCTIONAL IMPAIRMENT | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000825-35 | Sponsor Protocol Number: U1111-1167-2731 | Start Date*: 2015-08-27 | |||||||||||
Sponsor Name:Rigshospitalet Blegdamsvej | |||||||||||||
Full Title: The effect of the glucagon-like peptide-1 analogue, liraglutide (Victoza®), on jejunostomy output and intestinal absorption in short bowel syndrome patients, a double-blind cross-over study | |||||||||||||
Medical condition: Short bowel syndrome (SBS) is a clinical situation with reduced absorptive mucosal surface due to extensive surgical resection. SBS leads to increased intestinal losses of fluids and electrolytes; ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-001779-22 | Sponsor Protocol Number: 04.2017 | Start Date*: 2017-07-10 | |||||||||||
Sponsor Name:Aarhus University Hospital, Department of Endocrinology | |||||||||||||
Full Title: The Effect of Empagliflozin on Cardiac and Kidney Metabolism in Persons with Type 2 Diabetes | |||||||||||||
Medical condition: Diabetes, type 2 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004149-26 | Sponsor Protocol Number: METRIS-HF(EMPA) | Start Date*: 2018-06-26 |
Sponsor Name:Charité Universitätsmedizin Berlin | ||
Full Title: Effect of Metformin and Empagliflozin in insulin resistant patients with heart failure with reduced ejection fraction | ||
Medical condition: Heart Failure with reduced ejection fraction (HFrEF and HFmrEF) | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-001452-30 | Sponsor Protocol Number: 010815testis | Start Date*: 2015-12-07 | |||||||||||
Sponsor Name:Copenhagen University Hospital Rigshospitalet | |||||||||||||
Full Title: A Randomized double-blind study of testosterone replacement therapy or placebo in testicular cancer survivors with mild Leydig Cell Insufficiency (Einstein-intervention) | |||||||||||||
Medical condition: Leydig Cell dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000237-48 | Sponsor Protocol Number: MiraBAT01 | Start Date*: 2016-04-20 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: The effect of Mirabegron on brown adipose tissue in healthy young white Caucasian and South Asian men | ||
Medical condition: Obesity and dyslipidemia | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-003532-39 | Sponsor Protocol Number: SitaBAT01 | Start Date*: 2014-11-24 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: The effect of sitagliptin on brown adipose tissue and whole-body metabolism in overweight pre-diabetic men | ||
Medical condition: Obesity, dyslipidemia and impaired glucose tolerance | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-000604-25 | Sponsor Protocol Number: R96-A6604-14-S22 | Start Date*: 2015-05-02 |
Sponsor Name:Danish Cancer Society Research Center | ||
Full Title: HBOT LYCA: Hyperbaric Oxygen Therapy to reduce Lymphoedema after Breast Cancer - an explorative clinical trial | ||
Medical condition: breast cancer related lymphedema | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: DK (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-001559-30 | Sponsor Protocol Number: SMKV-013-CP4 | Start Date*: 2017-09-13 | |||||||||||
Sponsor Name:Fresenius Kabi Deutschland GmbH | |||||||||||||
Full Title: Efficacy of long-term parenteral nutrition with SmofKabiven® E concomitant to chemo- and/or immunotherapy: A prospective, randomised, controlled, open, multicentre, two-stage, adaptive clinical tri... | |||||||||||||
Medical condition: Metastatic Non-Small Cell Lung Cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002693-35 | Sponsor Protocol Number: B3D-EW-GHDK | Start Date*: 2008-11-21 | |||||||||||
Sponsor Name:Eli Lilly and Company Ltd | |||||||||||||
Full Title: Comparison of the Effects of Teriparatide with those of Risedronate on Lumbar Spine Bone Mineral Density in Men and Postmenopausal Women with Low Bone Mass and a Recent Pertrochanteric Hip Fracture | |||||||||||||
Medical condition: Postmenopausal Women and Men with Low Bone Mass and a Recent Pertrochanteric Fracture | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) DE (Completed) GB (Completed) ES (Completed) IT (Completed) GR (Completed) SE (Completed) AT (Completed) FR (Completed) CZ (Completed) IE (Completed) FI (Completed) NO (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005547-17 | Sponsor Protocol Number: RHMNUT0048 | Start Date*: 2010-01-28 |
Sponsor Name:Southampton University Hospital NHS Trust | ||
Full Title: Refeeding risks in patients requiring nutrition support. A twin centre double-blind randomised controlled trial of parenteral nutrition support. | ||
Medical condition: Patients who have a non-functioning gastrointestinal tract require artifical intravenous nutrition. This is usally a result recent surgery or sepsis causing a reversible short term paralysis of th... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.